Well-being in multiple sclerosis research funding opportunity
The International Progressive MS Alliance has released a Request for Applications (RFA) as the first stage of funding for a research pipeline to test innovative outcomes or treatments focused on the well-being of people living with progressive MS. Proposals should be focused on at least one of the four symptom areas of fatigue, mobility including upper extremity impairment, pain, and/or cognitive impairment.
The RFA is the first stage of a research pipeline in which successful awards will demonstrate a strong expert team that offers the potential for novel therapeutic interventions or outcomes for progressive MS and has the potential to culminate with a large randomized controlled study (Stage 2) and implementation (Stage 3) for adoption into the larger healthcare system. Stage 1 is a planning grant of up to €100,000 that provides time and resources to develop ideas, collect preliminary data (if needed), and construct a research team to develop and present an efficacy research proposal.
An informational call was be held on 30 March to discuss this funding opportunity and can be viewed here: https://youtu.be/b44RtAMmFgw
The deadline for full submission is 15 May, 2023.